These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6894966)

  • 21. [Calcium phosphate metabolism during therapy with 1,25-dihydroxycholecalciferol [1,25 DHCC (Ro 21/5535)] in patients with advanced kidney insufficiency].
    Schulz W; Spiegel P; Gessler U; Delling G
    Verh Dtsch Ges Inn Med; 1978; (84):1297-301. PubMed ID: 741953
    [No Abstract]   [Full Text] [Related]  

  • 22. Calcitriol in disorders of bone and calcium metabolism.
    Riggs BL
    Clin Ther; 1980; 3(1):33-9. PubMed ID: 6893296
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of vitamin D on remaining kidney function after chronic kidney failure in preservation period patient].
    Inaguma D; Tatematsu M; Shinjo H; Suzuki S; Mishima T; Inaba S; Nakamura T; Kato T
    Clin Calcium; 2005 Sep; 15 Suppl 1():152-5; discussion 155. PubMed ID: 16272649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of metabolites and analogues of vitamin D in prospective renal transplant recipients.
    Cundy T; Kanis JA; Fraher L; Clemens TL; O'Riordan JL
    Clin Nephrol; 1981 May; 15(5):240-5. PubMed ID: 7018772
    [No Abstract]   [Full Text] [Related]  

  • 25. Proceedings: The use of metabolically-active derivatives of vitamin D in rickets and osteomalacia due to renal glomerular failure.
    Smith R; Henderson RG; Russell RG
    J Bone Joint Surg Br; 1975 May; 57(2):247-8. PubMed ID: 1141297
    [No Abstract]   [Full Text] [Related]  

  • 26. Concurrent measurement of plasma levels of vitamin D3 and five of its metabolites in normal humans, chronic renal failure patients, and anephric subjects.
    Lambert PW; DeOreo PB; Hollis BW; Fu IY; Ginsberg DJ; Roos BA
    J Lab Clin Med; 1981 Oct; 98(4):536-48. PubMed ID: 6270222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal function during calcitriol therapy in chronic renal failure.
    Bertoli M; Luisetto G; Ruffatti A; Urso M; Romagnoli G
    Clin Nephrol; 1990 Feb; 33(2):98-102. PubMed ID: 2311310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin D metabolites and calcium metabolism in patients with nephrotic syndrome and normal renal function.
    Goldstein DA; Haldimann B; Sherman D; Norman AW; Massry SG
    J Clin Endocrinol Metab; 1981 Jan; 52(1):116-21. PubMed ID: 6969729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [An importance of vitamin D metabolites assessment in patients with impaired renal function].
    Sulková S; Fortová M; Uhrová J; Zima T
    Vnitr Lek; 2004 Jul; 50(7):510-8. PubMed ID: 15323258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical use of synthetic 1,25-dihydroxycholecalciferol.
    Evans IM; Boulton-Jones M; Doyle FH; Joplin GF; Lockwood M; Matthews EW; MacIntyre I
    Calcif Tissue Res; 1976 Aug; 21 Suppl():236-41. PubMed ID: 782663
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of renal osteodystrophy with 1,25-dihydroxycholecalciferol.
    Velentzas C; Oreopoulos DG; Pierratos A; Meema HE; Rabinovich S; Meindok H; Husdan H; Murray TM; Ogilvie R; Katirtzoglou A
    Can Med Assoc J; 1981 Mar; 124(5):577-83. PubMed ID: 6894103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal hypophosphatemic rickets: growth acceleration after long-term treatment with 1,25-dihydroxyvitamin-D3.
    Chan JC; Lovinger RD; Mamunes P
    Pediatrics; 1980 Sep; 66(3):445-54. PubMed ID: 6893489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapy with vitamin D and D-metabolites].
    Flury W; Haldimann B
    Schweiz Med Wochenschr; 1981 Feb; 111(9):314-21. PubMed ID: 6261326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of age on the conversion of 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 by kidney of rat.
    Armbrecht HJ; Zenser TV; Davis BB
    J Clin Invest; 1980 Nov; 66(5):1118-23. PubMed ID: 6893596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increase of calcitriol during treatment with protein-reduced diet in patients with renal failure.
    Wilske J; Attman PO
    Nephron; 1994; 66(4):421-5. PubMed ID: 8015645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of uremic osteopathy. Effects of vitamin D metabolites and vitamin D analogs in chronic uremia and experimental renal insufficiency].
    von Herrath D; Kraft D; Schaefer K; Krempien B
    MMW Munch Med Wochenschr; 1974 Sep; 116(37):1573-8. PubMed ID: 4374654
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term therapy of uremic osteodystrophy in adults with calcitriol.
    Moorthy AV; Harrington AR; Mazess RB; Simpson DP
    Clin Nephrol; 1981 Aug; 16(2):93-100. PubMed ID: 6894893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of 5,6-trans-25-OH-cholecalciferol in patients needing dialysis with florid renal osteopathy: therapeutic management and treatment results].
    Cremer W; Graben N; Merguet P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1307-10. PubMed ID: 611841
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of 1,25(OH)2D3 and 24,25(OH)2D3 in the long-term treatment of renal osteodystrophy.
    Muirhead N; Catto GR; Edward N; Fraser RA; O'Riordan JL; Papapoulos SE; Adami S
    Proc Eur Dial Transplant Assoc; 1980; 17():543-7. PubMed ID: 6972529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.